Search Results - "Purtilo, DT"

Refine Results
  1. 1

    Chronic fatigue syndrome: a working case definition by Holmes, G P, Kaplan, J E, Gantz, N M, Komaroff, A L, Schonberger, L B, Straus, S E, Jones, J F, Dubois, R E, Cunningham-Rundles, C, Pahwa, S

    Published in Annals of internal medicine (01-03-1988)
    “…The chronic Epstein-Barr virus syndrome is a poorly defined symptom complex characterized primarily by chronic or recurrent debilitating fatigue and various…”
    Get more information
    Journal Article
  2. 2

    Correlation of mutations of the SH2D1A gene and Epstein-Barr virus infection with clinical phenotype and outcome in X-linked lymphoproliferative disease by Sumegi, Janos, Huang, Dali, Lanyi, Arpad, Davis, Jack D., Seemayer, Thomas A., Maeda, Akihiko, Klein, George, Seri, Marco, Wakiguchi, Hiroshi, Purtilo, David T., Gross, Thomas G.

    Published in Blood (01-11-2000)
    “…The purposes of this study were to determine the frequency of mutations in SH2D1A in X-linked lymphoproliferative disease (XLP) and the role of SH2D1A…”
    Get full text
    Journal Article
  3. 3

    Epstein-Barr virus-associated lymphoproliferative disorders by Purtilo, D T, Strobach, R S, Okano, M, Davis, J R

    Published in Laboratory investigation (01-07-1992)
    “…Herein we have provided a panorama of the clinical, histopathologic, and molecular biologic mechanisms of EBV-induced LPD particularly in immunosuppressed…”
    Get more information
    Journal Article
  4. 4

    Epstein-Barr viral DNA in tissues of Hodgkin's disease by Weiss, LM, Strickler, JG, Warnke, RA, Purtilo, DT, Sklar, J

    Published in The American journal of pathology (01-10-1987)
    “…Tissue specimens from 21 cases of Hodgkin's disease were examined for the presence of Epstein-Barr virus (EBV) and cytomegalovirus DNA by molecular…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Epstein-Barr-virus-induced oncogenesis in immune-deficient individuals by Purtilo, D T

    Published in The Lancet (British edition) (09-02-1980)
    “…Experimental and clinical evidence supports the notion that the Epstein-Barr virus (EBV) can become oncogenic in immune-deficient hosts. Renal transplant…”
    Get more information
    Journal Article
  7. 7

    Epstein-Barr virus infections in males with the X-linked lymphoproliferative syndrome by Grierson, H, Purtilo, D T

    Published in Annals of internal medicine (01-04-1987)
    “…A registry of persons with the X-linked lymphoproliferative syndrome, which is characterized by marked susceptibility to diseases induced by the Epstein-Barr…”
    Get more information
    Journal Article
  8. 8

    Autologous bone marrow transplantation for patients with relapsed Hodgkin's disease by Armitage, J O, Bierman, P J, Vose, J M, Anderson, J R, Weisenburger, D D, Kessinger, A, Reed, E C, Vaughan, W P, Coccia, P F, Purtilo, D T

    Published in The American journal of medicine (01-12-1991)
    “…High-dose therapy and autologous bone marrow transplantation (ABMT) are being increasingly utilized for the management of patients with relapsed Hodgkin's…”
    Get more information
    Journal Article
  9. 9

    Intermediate Lymphocytic Lymphoma: Immunophenotypic and Cytogenetic Findings by Weisenburger, Dennis D., Sanger, Warren G., Armitage, James O., Purtilo, David T.

    Published in Blood (01-06-1987)
    “…A detailed immunohistologic and cytogenetic analysis of 12 cases of intermediate lymphocytic lymphoma was performed. The characteristic immunophenotype of…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Epstein-Barr viral genome in lymph nodes from patients with Hodgkin's disease may not be specific to Reed-Sternberg cells by Masih, A, Weisenburger, D, Duggan, M, Armitage, J, Bashir, R, Mitchell, D, Wickert, R, Purtilo, DT

    Published in The American journal of pathology (01-07-1991)
    “…A possible etiologic role for Epstein-Barr virus (EBV) in Hodgkin's disease (HD) was investigated by probing for EBV genome in 52 biopsy specimens involved…”
    Get full text
    Journal Article
  12. 12

    Opportunistic cancers in patients with immunodeficiency syndromes by Purtilo, D T

    “…Patients with inherited or acquired immunodeficiency disorders are vulnerable to a broad spectrum of opportunistic infectious diseases, but a narrow spectrum…”
    Get more information
    Journal Article
  13. 13

    Simple assay for evaluation of Epstein-Barr virus specific cytotoxic T lymphocytes by Okano, Motohiko, Purtilo, David T.

    Published in Journal of immunological methods (18-08-1995)
    “…Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes (CTL) are considered to be one of major defenses against the activation of EBV infection. We have…”
    Get full text
    Journal Article
  14. 14

    Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus by Hanto, D W, Frizzera, G, Purtilo, D T, Sakamoto, K, Sullivan, J L, Saemundsen, A K, Klein, G, Simmons, R L, Najarian, J S

    Published in Cancer research (Chicago, Ill.) (01-11-1981)
    “…Six renal transplant recipients with abnormal lymphoproliferative disorders were studied in an attempt to define their clinical features and the role of…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Soluble interleukin 2 receptors in sera of Japanese patients with adult T cell leukemia mark activity of disease by Yasuda, N, Lai, PK, Ip, SH, Kung, PC, Hinuma, Y, Matsuoka, M, Hattori, T, Takatsuki, K, Purtilo, DT

    Published in Blood (01-04-1988)
    “…Serum concentrations of soluble interleukin 2 receptors (sIL 2R) were measured by an enzyme-linked immunosorbent assay (ELISA) in 30 patients with adult T cell…”
    Get full text
    Journal Article
  17. 17

    SCID mouse model of Epstein-Barr virus-induced lymphomagenesis of immunodeficient humans by Purtilo, D T, Falk, K, Pirruccello, S J, Nakamine, H, Kleveland, K, Davis, J R, Okano, M, Taguchi, Y, Sanger, W G, Beisel, K W

    Published in International journal of cancer (20-02-1991)
    “…Immunodeficient humans are at very high risk of developing Epstein-Barr virus (EBV)-induced lymphomagenesis. Severe combined immunodeficient mice (SCID) have…”
    Get more information
    Journal Article
  18. 18

    Chemotherapy for diffuse large-cell lymphoma--rapidly responding patients have more durable remissions by Armitage, J O, Weisenburger, D D, Hutchins, M, Moravec, D F, Dowling, M, Sorensen, S, Mailliard, J, Okerbloom, J, Johnson, P S, Howe, D

    Published in Journal of clinical oncology (01-02-1986)
    “…Fifty-one patients with diffuse large-cell lymphoma (DLCL) were treated with a six-drug combination chemotherapy regimen including cyclophosphamide,…”
    Get more information
    Journal Article
  19. 19

    Characterization of Epstein-Barr virus-induced lymphoproliferation derived from human peripheral blood mononuclear cells transferred to severe combined immunodeficient mice by Okano, M, Taguchi, Y, Nakamine, H, Pirruccello, SJ, Davis, JR, Beisel, KW, Kleveland, KL, Sanger, WG, Fordyce, RR, Purtilo, DT

    Published in The American journal of pathology (01-09-1990)
    “…Mice with severe combined immunodeficiency (SCID) received 6 X 10(7) fresh human peripheral blood mononuclear cells (PBMC) intraperitoneally from Epstein-Barr…”
    Get full text
    Journal Article
  20. 20

    Fatal infectious mononucleosis and virus-associated hemophagocytic syndrome by Mroczek, E C, Weisenburger, D D, Grierson, H L, Markin, R, Purtilo, D T

    “…A detailed clinicopathologic analysis of 52 cases of fatal infectious mononucleosis was performed. Fever, rash, generalized lymphadenopathy,…”
    Get more information
    Journal Article